RE: Glass almost empty?25 Mar 2020 19:48
Thoth2,
Valirx's shareholders are not oncologists - why would they buy the IP when they have even less understanding than the BOD do on how to monetise it (and, as we know, the BOD have not been able to monetise the IP to date)?